Log In
Print this Print this

oral H1N1 influenza vaccine (VXA-A1.1)

  Manage Alerts
Collapse Summary General Information
Company Vaxart Inc.
DescriptionOral, monovalent vaccine against the H1N1 influenza virus
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationInfluenza virus
Indication DetailsVaccinate against H1N1 influenza virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today